Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Standard of Care for Postoperative Urinary Retention in Vaginal Hysterectomy
NCT05664633Phase 2Withdrawn
- Sponsor
- West Virginia University
- Start
- Aug 2023
- Primary completion
- Jun 2024
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 2 trial of Sugammadex in postoperative urinary retention (POUR), sponsored by West Virginia University. Planned start Aug 2023; status: withdrawn.
02
Drugs
Sugammadex
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT05664633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664633.